Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Revenue: 2020-2022

Historic Revenue for Immuneering (IMRX) over the last 3 years, with Dec 2022 value amounting to $455.

  • Immuneering's Revenue fell 99.76% to $455 in Q4 2022 from the same period last year, while for Dec 2022 it was $316,952, marking a year-over-year decrease of 84.76%. This contributed to the annual value of $316,952 for FY2022, which is 84.76% down from last year.
  • Immuneering's Revenue amounted to $455 in Q4 2022, which was down 98.81% from $38,380 recorded in Q3 2022.
  • Immuneering's 5-year Revenue high stood at $748,200 for Q1 2021, and its period low was $455 during Q4 2022.
  • In the last 3 years, Immuneering's Revenue had a median value of $482,130 in 2021 and averaged $384,328.
  • In the last 5 years, Immuneering's Revenue skyrocketed by 36.64% in 2021 and then crashed by 99.76% in 2022.
  • Quarterly analysis of 3 years shows Immuneering's Revenue stood at $665,080 in 2020, then slumped by 71.49% to $189,591 in 2021, then tumbled by 99.76% to $455 in 2022.
  • Its Revenue stands at $455 for Q4 2022, versus $38,380 for Q3 2022 and $94,419 for Q2 2022.